XML 29 R14.htm IDEA: XBRL DOCUMENT v3.20.2
1. Nature of Business and Basis of Presentation (Policies)
6 Months Ended
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation

The unaudited financial statements of the Company for the three and six month periods ended June 30, 2020 and 2019 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-K. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. However, such information reflects all adjustments (consisting solely of normal recurring adjustments), which are, in the opinion of management, necessary for the fair presentation of the financial position and the results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full fiscal year. The balance sheet information as of June 30, 2020 was derived from the audited financial statements included in the Company's financial statements as of and for the year ended December 31, 2019 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on May 1, 2020. These financial statements should be read in conjunction with that report.

Recently Issued Accounting Pronouncements

In January 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2018-01, LEASES (TOPIC 842): LAND EASEMENT PRACTICAL EXPEDIENT FOR TRANSITION TO TOPIC 842. In February 2016, the FASB issued Accounting Standards Update No. 2016- 02, Leases (Topic 842), to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing transactions. The Company adopted this pronouncement on January 1, 2019. The Company's month-to-month arrangement for office space has no short-term or long-term asset or liability value.

Discontinued Operations

Effective April 1, 2019 the Company disposed of its Atlas Pharma Inc. subsidiary. As a consequence of the sale, the operating results and the assets and liabilities of the discontinued operations, which formerly comprised the Analytical Chemistry Services Operations, are presented separately in the Company's financial statements. Summarized financial information for the discontinued business is shown below. Prior period balances have been reclassified to present the operations of the Analytical Chemistry Services business as a discontinued operation.

 

Discontinued Operations Income Statement:

 

    Unaudited     Unaudited  
   

6 Month

and 3 month

Ended

   

6 Month

and

3 month Ended

 
    June 30, 2020     June 30, 2019  
             
Revenues   $ -     $ 119,522  
Cost of revenues     -       81,920  
Gross profit     -       37,602  
                 
General & Administrative Expenses     -       36,196  
Gain (Loss) from operations     -       1,406  
                 
Other income (expense) – Interest     -       (3,518 )
Net Income (Loss) from discontinued operations     -     (2,112 )
Loss on Disposal       (580,125      (580,125
Total Net Income (Loss) from Discontinued Operations     (580,125    (582,237

 

Discontinued Operations Balance Sheet:

 

    Unaudited     Unaudited  
    June 30, 2020     June 30, 2019  
ASSETS            
Current Assets:                                             
Cash and cash equivalents   $ -     $ 4,682  
Accounts receivable     -       94,955  
Total Current Assets     -       99,637  
                 
Equipment (net of $-0- and $34,959 depreciation)     -       224,238  
Goodwill     -       665,697  
TOTAL ASSETS     -       989,572  
                 
LIABILITIES                
Current Liabilities:                
Notes payable     -       4,657  
Notes payable - related party     -       18,230  
Related party advances     -       10,248  
Accounts payable and accrued expenses     -       70,597  
Total Current Liabilities     -       103,732  
TOTAL LIABILITIES   $ -     $ 103,732  

 

Discontinued Operations Cash Flows:

 

Cash flows used in discontinued operations for the six months ended June 30, 2020 and 2019 were $-0- and $8,510, respectively. There were no cash flows used in or provided by financing or investing activities during those periods.

 

Revenue Recognition

As of January 1, 2018, the Company adopted ASU No. 201409, “Revenue from Contracts with Customers” (ASC 606). Under the new guidance, an entity will recognize revenue to depict the transfer of promised goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. A five-step model has been introduced for an entity to apply when recognizing revenue. The new guidance also includes enhanced disclosure requirements.

 

Local governmental regulations in Canada require that companies recognize revenues upon completion of the work by issuing an invoice and remitting the applicable sales taxes (GST and QST) to the appropriate government agency. The Company’s revenue recognition policy is in compliance with these local regulations.